Driving Innovation: Global Strides to #MakeHIVHistory

Add this event to your calendar:
01/12/2017 11:00 01/12/2017 12:30 America/New_York Driving Innovation: Global Strides to #MakeHIVHistory Joseph B. Martin Conference Center , 77 Ave Louis Pasteur , Boston , MA Johnson & Johnson Innovation false DD/MM/YYYY

Driving Innovation: Global Strides to #MakeHIVHistory

Joseph B. Martin Conference Center , 77 Ave Louis Pasteur , Boston , MA

December 01, 2017 from 11:00 AM to 12:30 PM (EST)

$10 - $35

Join the AIDS Action Committee and Johnson & Johnson Innovation on December 1 2017, for Driving Innovation: Global Strides to #MakeHIVHistory.

Driving Innovation: Global Strides to #MakeHIVHistory will feature a robust panel discussion about the global HIV burden, ongoing research progress, and the need for multiple solutions to end HIV.

Registration and refreshments will take place from 10:00 – 10:30 a.m. before the panel discussion begins.

Featured Speakers

Dr. Dan Barouch M.D., Ph.D. | Professor of Medicine, Director of the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center 

Nicola La Monica, Ph.D. | Senior Director, Infectious Disease & Vaccines Scientific Innovation, Janssen, Pharmaceutical Companies of Johnson & Johnson

Dr. Zeda Rosenberg, ScD | Founder and CEO, International Partnerships for Microbicides

Carl Sciortino | Executive Director, AIDS Action Committee 

Karen Weintraub | Independent Health/Science Journalist

Event partners

FREE | There is no cost to attend this workshop, but pre-registration is required.

Johnson & Johnson Innovation

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com or follow @JNJInnovation.

Event contact

Related content